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Transferrin (Tf) is a liver-derived iron transport pro-
tein whose plasma concentration increases following ex-
posure to hypoxia. Here, we present a cell culture model
capable of expressing Tf mRNA in an oxygen-dependent
manner. A 4-kilobase pair Tf promoter/enhancer frag-
ment as well as the 300-base pair liver-specific Tf en-
hancer alone conveyed hypoxia responsiveness to a het-
erologous reporter gene construct in hepatoma but not
HeLa cells. Within this enhancer, a 32-base pair hypoxia-
responsive element was identified, which contained two
hypoxia-inducible factor-1 (HIF-1) binding sites (HBSs).
Mutation analysis showed that both HBSs function as
oxygen-regulated enhancers in Tf-expressing as well as
in non-Tf-expressing cell lines. Mutation of both HBSs
was necessary to completely abolish hypoxic reporter
gene activation. Transient co-expression of the two
HIF-1 subunits HIF-1a and aryl hydrocarbon receptor
nuclear translocator (ARNT)/HIF-1b resulted in en-
hanced reporter gene expression even under normoxic
conditions. Overexpression of a dominant-negative
ARNT/HIF-1b mutant reduced hypoxic activation. DNA
binding studies using nuclear extracts from the mouse
hepatoma cell line Hepa1 and the ARNT/HIF-1b-defi-
cient subline Hepa1C4, as well as antibodies raised
against HIF-1a and ARNT/HIF-1b confirmed that HIF-1
binds the Tf HBSs. Mutation analysis and competition
experiments suggested that the 5* HBS was more effi-
cient in binding HIF-1 than the 3* HBS. Finally, hypoxic
induction of endogenous Tf mRNA was abrogated in
Hepa1C4 cells, confirming that HIF-1 confers oxygen
regulation of Tf gene expression by binding to the two
HBSs present in the Tf enhancer.
Iron is an essential trace metal in all living organisms. Both
iron overload and iron depletion can severely affect physiolog-
ical processes such as development, erythropoiesis, or biochem-
ical metabolism (reviewed in Refs. 1 and 2). The liver repre-
sents the major organ of iron storage in the body and is most
susceptible to injuries due to iron overload (1). Thus, iron
hemostasis has to be tightly balanced, and, as a consequence,
free iron occurs only transiently in the serum. When iron is
absorbed from the small intestine into the blood, it immediately
binds apotransferrin to form transferrin (Tf)1, which is then
transported by the plasma to all tissues of the vertebrate’s
body. Delivery of iron occurs by binding of Tf to the Tf receptor
followed by endocytosis. In erythroblasts, iron is primarily re-
quired for heme synthesis in mitochondria. Tissue-specific ex-
pression of the Tf gene is controlled by distinct positive and
negative regulatory elements located 59 to the transcription
initiation site. Apart from the promoter, the best studied ele-
ment within this region is the 23600/23300 enhancer (hereaf-
ter referred to as the Tf enhancer). This cis-acting element
enhances the activity of the Tf promoter in human Hep3B
hepatoma cells in a tissue-specific manner (3, 4). Studies in
Hep3B and HeLa cells revealed that multiple liver-enriched
and ubiquitous factors interact with the Tf enhancer (3, 5, 6).
The Tf enhancer, however, is inactive in Tf-expressing neuro-
nal and Sertoli cells (4, 5).
Hypoxia, a reduction in oxygen concentration, is increasingly
recognized as an important regulator of gene expression (re-
viewed in Ref. 7). The best established example of oxygen-
regulated gene expression is provided by the erythropoietic
growth factor erythropoietin (Epo, reviewed in Ref. 8). The two
human hepatoma cell lines HepG2 and Hep3B are so far the
only permanent cell culture models available to investigate
oxygen-regulated Epo expression (9). Apart from Epo, we re-
cently demonstrated hypoxic induction of several acute phase
genes in HepG2 cells (10). Acute phase reactants are liver-
derived serum proteins whose production is induced by proin-
flammatory cytokines (reviewed in Ref. 11). Tf expression was
of particular interest since this protein is one of the rare ex-
amples of acute phase reactants that are down-regulated dur-
ing the acute phase response in both human serum and HepG2
cells (11). In contrast, we found a marked increase in Tf tran-
scription following hypoxic (1% O2) culture of HepG2 cells (10),
suggesting that different signaling pathways are mediating the
effects of these two stimuli. Given that the erythroid marrow
uses more than 80% of plasma iron (2), and considering that
hypoxia increases erythropoiesis, it is conceivable that an in-
crease in plasma iron transport capacity is required for hy-
poxia-induced Epo-mediated erythropoiesis. Indeed, hypoxia
was shown to increase iron absorption (12), and hypoxic up-
regulation of Tf serum protein concentrations has previously
been found in mice (13) and rats (14, 15) exposed to hypobaric
hypoxia (0.5 atm) for 1–3 days. Although some of these exper-
iments were established some 40 years ago, the molecular
mechanisms leading to hypoxically enhanced Tf expression
have not been unraveled so far, mainly due to the lack of a
suitable cell culture model.
The hypoxia-inducible factor-1 (HIF-1) was originally iden-
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tified by its ability to bind to a hypoxia-responsive cis-element
located 39 to the Epo gene (16). HIF-1 is a heterodimer consist-
ing of an a and a b subunit, both belonging to the basic-helix-
loop-helix-Per-AhR/ARNT-Sim family of transcription factors
(17). Whereas the a subunit is a novel member of this family,
the b subunit is identical to the aryl hydrocarbon receptor
nuclear translocator (ARNT) known to heterodimerize with the
aryl hydrocarbon receptor/dioxin receptor (AhR) following li-
gand binding (reviewed in Refs. 7 and 18).
We have established cell culture models to study oxygen-de-
pendent Tf expression and have subsequently analyzed the
regulation of the Tf enhancer. Our results demonstrate the
presence of two HIF-1 binding sites (HBSs) within the Tf en-
hancer and show that binding of HIF-1 to these sites confers
oxygen-regulated Tf gene expression.
MATERIALS AND METHODS
Cell Culture and Hypoxic Induction—The human hepatoma cell lines
Hep3B and HepG2 were obtained from American Type Culture Collec-
tion (ATCC numbers HB-8064 and HB-8065, respectively). The mouse
hepatoma cell lines Hepa1 (also termed Hepa1c1c7) and Hepa1C4 (19)
were kind gifts of L. Poellinger (Karolinska Institute, Stockholm, Swe-
den). All cells were cultured in Dulbecco’s modified Eagle’s medium
(high glucose, Life Technologies, Inc.) supplemented with 10% heat-
inactivated fetal calf serum (Boehringer Mannheim), 100 units/ml pen-
icillin, 100 mg/ml streptomycin, 1 3 non-essential amino acids, 2 mM
L-glutamine, and 1 mM sodium pyruvate (all Life Technologies, Inc.) in
a humidified atmosphere containing 5% CO2 at 37 °C. Oxygen tensions
in the incubator (Forma Scientific, model 3319) were either 140 mm Hg
(20% O2, v/v, normoxia) or 7 mm Hg (1% O2, v/v, hypoxia). Cells were
subjected to hypoxic induction at a cell density of 2 3 105 cells/cm2. The
human epitheloid carcinoma cell line HeLaS3 (ATCC CCL-2.2) was
cultured in suspension in Ham’s F-12 medium (Life Technologies, Inc.)
supplemented as described above. Hypoxic induction was achieved as
described elsewhere (20). Briefly, HeLaS3 cells were incubated at a
density of 1 3 107 cells/ml in an IL 237 tonometer (Instrumentation
Laboratory) under continuous stirring for 4 h at 37 °C using gas mix-
tures of either 20% O2, 5% CO2, and 75% N2 (normoxia), or 1% O2, 5%
CO2 and 94% N2 (hypoxia) at a flow rate of 500 ml/min.
RNA Blot Analysis—Immediately following stimulation, RNA was
isolated as described by Chomczynski and Sacchi (21). Total RNA (10
mg) was denatured in formamide/formaldehyde and electrophoresed
through a 1% agarose gel containing 6% formaldehyde as described
(22). Following pressure blotting (Stratagene) to nylon membranes
(Biodyne A, Pall) and UV cross-linking (Stratalinker, Stratagene), the
filters were hybridized to cDNA probes labeled with [a-32P]dCTP to a
specific activity of 1 3 109 dpm/mg using the random-primed DNA
labeling method (22). Hybridization was performed in 50% formamide,
10% dextran sulfate, 5 3 Denhardt’s solution, 200 mg/ml sonicated
salmon sperm DNA, 1% SDS, 0.9 M NaCl, 60 mM NaH2PO4, 6 mM EDTA
(pH 7.0) for 14 h at 42 °C. The filters were washed to a final stringency
of 55 °C in 0.1 3 SSC, 0.2% SDS and the signals recorded using a
PhosphorImager (Molecular Dynamics). The Tf, a1-antitrypsin, b-actin,
ribosomal protein L28, and 28 S ribosomal RNA cDNA probes were
obtained as described previously (10, 23). All probes were purified free
of vector sequences by restriction digestion and agarose gel purification.
Plasmid Constructs—pGLTf4000 was constructed by insertion of the
4-kb KpnI-BamHI fragment from the Tf promoter/enhancer-containing
plasmid pTfCAT (kindly provided by M. M. Zakin, Institut Pasteur,
Paris, France) into the KpnI-BglII sites of pGL3Basic (Promega). Lu-
ciferase reporter gene constructs containing the heterologous SV40
promoter were obtained by inserting the DNA sequences of interest into
the BamHI site 39 to the luciferase gene of the pGL3Promoter plasmid
(Promega). The liver-specific Tf enhancer from nucleotide position 23.6
kb to 23.3 kb relative to the transcriptional start site (3) was obtained
by polymerase chain reaction amplification of genomic DNA using the
oligonucleotide primers 59-GGTCAGGCAGAGGACACTG-39 and 59-
CAGTTCTAGACCAACCCAAG-39. The oligonucleotides containing
wild type and mutated HBSs are shown in Fig. 4. Copy number and
orientation were determined using RVprimer4 (Promega) by T7 poly-
merase-mediated single-stranded DNA sequencing following the man-
ufacturer’s instructions (Pharmacia Biotech Inc.). The b-galactosidase
expression vector pCMVlacZ was a kind gift of S. Kozlov (Institute of
Biochemistry, Zu¨rich, Switzerland). The HIF-1a (pCMVhHIF-1a) and
ARNT/HIF-1b (pCMVhARNT and pCMVDbARNT) expression vectors
(19) were generously provided by L. Poellinger.
Transient Transfections and Reporter Gene Assays—Hep3B, HepG2,
and HeLa cells (0.2–1 3 107 in 350 ml of medium without fetal calf
serum) were co-transfected with 25 mg each of luciferase and b-galac-
tosidase reporter gene constructs by electroporation at 250 V and 960
microfarads (Gene Pulser, Bio-Rad). After recovering, the cells were
split in two aliquots and incubated for 36 h at 20% or 1% O2, respec-
tively. After washing twice with phosphate-buffered saline, the cells
were lysed in reporter lysis buffer (Promega) and luciferase and b-ga-
lactosidase activities were determined according to the manufacturer’s
instructions (Promega) using a Biocounter M1500 luminometer (Lu-
mac) and a DU-62 spectrophotometer (Beckman), respectively. Differ-
ences in the transfection efficiency and extract preparation were cor-
rected by normalization to the corresponding b-galactosidase activities.
Luciferase activities were expressed relative to the empty parental
vector (pGL3Basic or pGL3Promoter) transfectants. For transient over-
expression assays in Hep3B cells, 10 mg of each expression vector was
co-transfected together with equal amounts of the luciferase reporter
construct pTfHBSww and the control plasmid pCMVlacZ. The unre-
lated vector plasmid pBluescript (Stratagene) was added to adjust the
total amount of DNA per electroporation to 50 mg.
Nuclear Extract Preparation—Nuclear extracts were prepared as
described previously (24). Briefly, 1 3 108 cells were washed twice with
ice-cold phosphate-buffered saline and once with buffer A (10 mM Tris-
HCl (pH 7.8), 1.5 mM MgCl2, 10 mM KCl). After incubation on ice for 10
min, the cells were lysed by 10 strokes of a Dounce homogenizer, and
the nuclei were pelleted and resuspended in buffer C (420 mM KCl, 20
mM Tris-HCl (pH 7.8), 1.5 mM MgCl2, 20% glycerol) and incubated at
4 °C for 30 min with gentle agitation. Immediately before use, buffers A
and C were supplemented with 0.5 mM dithiothreitol, 0.4 mM phenyl-
methylsulfonyl fluoride, 2 mg/ml each of leupeptin, pepstatin, and apro-
tinin, and 1 mM Na3VO4 (all obtained from Sigma). The nuclear extract
was centrifuged, and the supernatant was dialyzed twice against buffer
D (20 mM Tris-HCl (pH 7.8), 100 mM KCl, 0.2 mM EDTA, 20% glycerol).
Protein concentrations were determined using the Bradford protein
assay (Bio-Rad) with bovine serum albumin as standard.
Electrophoretic Mobility Shift Assay (EMSA)—Sequences of the oli-
gonucleotide probes used for EMSA are shown in Fig. 4. The EPOHBS
oligonucleotides have been described previously (24). All oligonucleo-
tides (Microsynth) were purified on 10% polyacrylamide gels prior to 59
end-labeling of the sense strand with [g-32P]ATP (Hartmann) using
T4-polynucleotide kinase (Fermentas). Unincorporated nucleotides
were removed by gel filtration over Bio-Gel P60 (fine) columns (Bio-
Rad). Labeled sense strands were annealed to a 2-fold molar excess of
unlabeled antisense strands. DNA-protein binding reactions were car-
ried out for 20 min at 4 °C in a total volume of 20 ml containing 4–5 mg
of nuclear extract, 0.1–0.4 mg of sonicated, denatured calf thymus DNA
(Sigma), and 1 3 104 cpm of oligonucleotide probe in 10 mM Tris-HCl
(pH 7.5), 50 mM KCl, 50 mM NaCl, 1 mM MgCl2, 1 mM EDTA, 5 mM
dithiothreitol, and 5% glycerol and run on 4% non-denaturing poly-
acrylamide gels. Electrophoresis was performed at 200 V in TBE buffer
(89 mM Tris, 89 mM boric acid, 5 mM EDTA) at 4 °C, and dried gels were
autoradiographed. For supershift analysis, each 1 ml of rabbit poly-
clonal antisera derived against HIF-1a or ARNT/HIF-1b (kind gift of L.
Poellinger) was added to the completed EMSA reaction mixture and
incubated for 16 h at 4 °C prior to loading. For competition experiments,
a 4–500-fold molar excess of unlabeled annealed oligonucleotides was
added to the binding reaction prior to addition of labeled probes.
RESULTS
Oxygen-regulated Tf mRNA Expression in Two Human Hep-
atoma Cell Lines—We previously reported on oxygen-regulated
mRNA expression of several acute phase genes in the human
hepatoma cell line HepG2 (10). Regulation of the Tf gene was of
special interest since Tf transcription was down-regulated in
response to proinflammatory cytokines (e.g. interleukin-6), but
was up-regulated following exposure to low oxygen concentra-
tions. To test whether hypoxic Tf induction observed in HepG2
cells might represent a general phenomenon in liver cells, we
also exposed Hep3B cells, another human hepatoma cell line, to
1% O2 for 1–3 days. As shown by RNA blotting experiments, Tf
mRNA was up-regulated about 1.5-fold in Hep3B cells (Fig. 1A)
and up to 4.5-fold in HepG2 cells (Fig. 1B). A similar hypoxic
induction pattern of endogenous gene expression in the two cell
lines was observed for the acute phase reactant a1-antitrypsin,
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which was included as positive control (Fig. 1, A and B). Spec-
ificity of hypoxic up-regulation was shown using L28 and 28 S
control hybridizations since b-actin mRNA was also slightly
up-regulated in both hepatoma cell lines and thus not suitable
as a normalization probe (10).
The Tf Enhancer Is Hypoxia-responsive—In a first attempt to
identify Tf regulatory sequences conveying hypoxia-inducible
Tf transcription, a 24000 to 139 (numbering according to Ref.
3) Tf promoter/enhancer DNA fragment (Fig. 2A) was inserted
upstream of a promoterless luciferase reporter gene vector.
Following transient transfection into Tf-expressing Hep3B and
HepG2 cells, as well as into non-Tf-expressing HeLa cells, this
4-kb Tf promoter/enhancer induced basal luciferase expression
10-, 26-, and 8-fold in Hep3B, HepG2 and HeLa cells, respec-
tively (Fig. 2B, open bars). Hypoxia (1% O2) stimulated lucif-
erase expression 4.1- and 5.6-fold in Hep3B and HepG2 cells,
respectively, but no significant hypoxic induction could be ob-
served in HeLa cells (Fig. 2B, filled bars). Thus, hypoxia re-
sponsiveness seems to be coupled to liver-specific cis-acting
elements present within this Tf promoter/enhancer DNA
fragment.
In analogy to the liver-specific enhancer and the hypoxia-
responsive element residing in close vicinity in the Epo 39
flanking region (16), we wondered whether the 23600/23300
bp liver-specific Tf enhancer (Fig. 2A) might be responsible for
oxygen responsiveness of the Tf gene. To test this, we subcloned
the 300-bp Tf enhancer downstream of a luciferase reporter
gene driven by a heterologous SV40 promoter. The Tf enhancer
induced normoxic luciferase expression by 8.1-, 1.6-, and 2.0-
fold in Hep3B, HepG2, and HeLa cells, respectively (Fig. 3,
open bars). This expression level was further up-regulated by
exposing the cells to hypoxia; luciferase activity in Hep3B,
HepG2, and HeLa cells increased 3.1-, 6.8-, and 1.8-fold, re-
spectively (Fig. 3, filled bars). The weak hypoxic inducibility
(1.4-fold) of the pGL3Promoter plasmid itself has been reported
previously (24). Thus, similar to the observations using the
4-kb Tf promoter/enhancer, the 300-bp Tf enhancer alone con-
ferred hypoxia inducibility in Hep3B and HepG2 hepatoma
cells, but was not significantly active in non-Tf-expressing
HeLa cells.
Two Tandemly Repeated HBSs Confer Hypoxia Responsive-
ness to the Tf Gene—A computer-assisted search using a HIF-1
consensus DNA-binding site (24) as query revealed the pres-
ence of two tandemly arrayed putative HBSs beginning at
nucleotide positions 174 and 191, respectively (Fig. 4), within
the 300-bp Tf enhancer (numbering according to Ref. 3). No
other matches to the HIF-1 query were found in the published
nucleotide sequences of the Tf gene. To test whether these two
putative HBSs were functionally oxygen-responsive, we syn-
thesized oligonucleotides containing both sites in either the
wild type configuration (TfHBSww), or with one (TfHBSwm or
FIG. 1. RNA blot analysis of hypoxic Tf mRNA induction. Hu-
man Hep3B (A) and HepG2 (B) hepatoma cell lines were exposed to
hypoxia as indicated. Hybridization with cDNA probes derived from the
ribosomal protein L28 or the ribosomal RNA 28 S served as controls for
equal loading and blotting efficiency.
FIG. 2. Hypoxia responsiveness of the Tf 5* flanking region. A,
structural organization of the 59 flanking region of the Tf gene (accord-
ing to Ref. 4). B, luciferase reporter gene activity following transient
transfection and hypoxic induction for 36 h of Hep3B, HepG2, and HeLa
cells with luciferase expression plasmids containing the 4-kb Tf pro-
moter/enhancer. A co-transfected b-galactosidase expression vector
served as internal control for transfection efficiency and extract prep-
aration. All values were normalized to the normoxic luciferase activities
obtained with the empty pGL3Basic vector which were arbitrarily de-
fined as 1. Means 6 S.D. of three to four independent experiments are
shown.
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TfHBSmw) or both (TfHBSmm) HBS sites mutated (Fig. 4).
Single copies of these oligonucleotides were inserted 39 to a
luciferase reporter gene driven by a heterologous SV40 pro-
moter. For comparison, a hypoxia-responsive luciferase con-
struct (pGLEPOHBS.3) containing three concatamerized cop-
ies of the Epo HBS was included in this study (24). Luciferase
activity was determined following transient transfection of
Hep3B and HeLa cells, splitting in two aliquots and 36 h of
normoxic or hypoxic cell culture. Compared with the normoxic
control cells, hypoxia increased luciferase expression from the
control plasmid (pGLEPOHBS.3) 4.1- and 6.8-fold in Hep3B
and HeLa cells, respectively (Fig. 5). Hypoxic induction medi-
ated by the two tandemly arrayed, putative Tf HBSs (pGLTf-
HBSww) was more effective in Hep3B cells (9.4-fold) than in
HeLa cells (3.7-fold). Although again less pronounced in HeLa
cells compared with Hep3B cells (similar to the 300-bp Tf
enhancer; see Fig. 3), the putative Tf HBSs functioned as
hypoxia-dependent enhancer in both cell lines that do or do not
express Tf (Fig. 5). This observation is reminiscent of the Epo
HBS, which has previously been reported to enhance hypoxic
gene expression in Epo-expressing and non-Epo-expressing cell
lines (25, 26). Mutation of either one of the two putative Tf
HBSs (plasmids pGLTfHBSwm and pGLTfHBSmw) only par-
tially reduced hypoxic luciferase expression, and a double mu-
tation of both sites (plasmid pGLTfHBSmm) was necessary to
completely abrogate oxygen responsiveness down to the basal
level observed with the empty vector alone (Fig. 5).
HIF-1 Activates Reporter Gene Expression via the Tf
HBS—To investigate the involvement of the HIF-1 protein
complex in Tf regulation, we performed transient expression
experiments using the HIF-1a and/or ARNT/HIF-1b expres-
sion vectors pCMVhHIF-1a and pCMVhARNT, respectively
(19). They were co-transfected into Hep3B cells together with
the reporter gene construct pGLTfHBSww (depicted in Fig. 5),
the normalization plasmid pCMVlacZ and the unrelated plas-
mid pBluescript used to equalize the total amount of DNA per
transfection. As shown in Fig. 6 (open bars), transient overex-
pression, under normoxic conditions, of either of the two HIF-1
subunits weakly (about 2-fold) induced reporter gene expres-
sion, whereas expression of both HIF-1 subunits induced lucif-
erase expression by 5.8-fold (Fig. 6, open bars). Co-expression
with a reporter gene construct containing mutant HBSs
(pGLTfHBSmm) did not result in enhanced luciferase expres-
FIG. 3. Hypoxia responsiveness of the Tf enhancer. SV40 pro-
moter-driven luciferase constructs with or without the 300-bp Tf en-
hancer (23600 to 23300) were transiently transfected into Hep3B,
HepG2 and HeLa cells. After 36 h of normoxic or hypoxic culture,
luciferase activities were determined as described in Fig. 2. Means 6
S.D. of three independent experiments are shown.
FIG. 4. Oligonucleotides carrying wild type (w) and mutant (m)
HBSs derived from the Epo (24) and Tf genes (3). Note that for
better comparison the complementary strand of EPOHBS is shown
twice.
FIG. 5. The Tf enhancer contains two functional HBSs. Lucifer-
ase reporter gene constructs containing three copies of the EPOHBS
(W) or a single copy of the two tandemly arrayed putative HBSs derived
from the Tf enhancer (see Fig. 4) were transiently transfected into
Hep3B and HeLa cells. Following normoxic or hypoxic exposure for
36 h, luciferase activity was determined as described in Fig. 2. Means 6
S.D. of 3–10 independent experiments are shown.
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sion (data not shown), implying that HIF-1 needs to bind to the
Tf HBSs to transactivate reporter gene expression. Hypoxia
also activated the Tf HBSs (Fig. 6, filled bars), and overexpres-
sion of the two HIF-1 subunits further enhanced this effect
1.8-fold. Interestingly, overexpression of a dominant negative
ARNT/HIF-1b mutant (pCMVDbARNT), which lacks the basic
domain and hence is still capable of heterodimerizing with
HIF-1a but cannot bind DNA (19), reduced reporter gene ex-
pression by sequestering endogenous as well as overexpressed
HIF-1a (Fig. 6), underlining the critical role of HIF-1 in hypoxic
Tf induction.
DNA Binding of HIF-1 to the Two HBS Sites of the Tf En-
hancer—To directly identify the endogenous transcription fac-
tor(s) binding to the HBS of the Tf enhancer, EMSAs were
performed using the TfHBS oligonucleotides shown in Fig. 4 as
probes. Following incubation of the TfHBSww probe with nu-
clear extracts derived from normoxic or hypoxic Hep3B cells,
nonspecific, constitutive, and hypoxia-inducible factors were
detected (Fig. 7A). Using Hep3B nuclear extracts, mutation of
the 39 HBS site (oligonucleotide TfHBSwm) did not greatly
affect binding of the hypoxia-inducible factor. In contrast, mu-
tation of the 59 HBS site present in the Tf enhancer (oligonu-
cleotide TfHBSmw) strongly reduced but (as could be seen after
prolonged exposure, data not shown) did not completely abolish
protein binding. Only the double mutation (oligonucleotide Tf-
HBSmm) completely abolished binding of both the hypoxia-
inducible and the constitutive factor, indicating that both sites
are capable of binding these two factors although with different
affinities. Interestingly, in Hep3B cells, constitutive factor
binding was found only with single mutations but not with the
wild type or double mutant probe. To date, we have no expla-
nation for this observation. In the case of the Epo HBS, we
previously identified the constitutive factor as ATF-1/CREB-1
family members contacting similar nucleotide residues as
HIF-1 itself (24). Similar constitutive and hypoxia-inducible
factors derived from the non-Tf-expressing human HeLa cervi-
cal carcinoma and mouse L929 fibroblast cells, as well as from
the Tf-expressing mouse Hepa1 hepatoma cells, also bound to
the TfHBSww probe (Fig. 7B). In contrast to Hep3B cells,
constitutive factor binding to the TfHBSww probe was detect-
able in all of these extracts.
To demonstrate that the hypoxia-inducible factor binding the
TfHBSww probe is indeed identical with the previously identi-
fied HIF-1 (17), nuclear extracts were prepared from normoxic
and hypoxic Hepa1C4 cells and analyzed by EMSA. The cell
line Hepa1C4, a subline of Hepa1 cells, is deficient in func-
tional ARNT/HIF-1b expression (19) and devoid of DNA bind-
ing activity to the EPOHBS probe as well as of reporter gene
induction with Epo HBS luciferase constructs (19). As shown in
Fig. 7B, this cell line also lacked hypoxia-inducible TfHBSww
DNA binding activity, whereas the constitutive and nonspecific
factors were still present. Moreover, rabbit polyclonal antibod-
ies derived against HIF-1a and ARNT/HIF-1b supershifted the
hypoxia-inducible factor binding to the EPOHBS probe as well
as to the TfHBS wild type and single mutated probes in Hepa1
cells (Fig. 7C), suggesting that this factor is functionally and
immunologically indistinguishable from HIF-1.
To analyze in more detail the binding of HIF-1 to the two
functional Tf HBSs, competition experiments were performed
using the labeled TfHBSww probe and increasing amounts of
unlabeled wild type or mutant oligonucleotides (depicted in
Fig. 4). As shown in Fig. 8, using nuclear extracts derived from
normoxic or hypoxic Hepa1 cells, the 39 single mutant oligonu-
cleotide (TfHBSwm) competed as efficiently for HIF-1 DNA
binding to the TfHBSww probe as the wild type TfHBSww
oligonucleotide itself (i.e. competition was observed using a
20-fold molar excess). The reduction in HIF-1 band intensity
with 20- and 100-fold molar excesses of the 59 single mutant
oligonucleotide (TfHBSmw) was somewhat less prominent,
confirming that although both Tf HBSs can bind HIF-1, the 39
site has a lower affinity for HIF-1. The double mutant TfHB-
Smm oligonucleotide did not compete for HIF-1 DNA binding
activity (Fig. 8). On the other hand, oligonucleotide EPOHBS
also competed for HIF-1 DNA binding to the TfHBSww probe,
although with a lower efficiency than TfHBSww itself (i.e. more
than a 100-fold molar excess was necessary for competition),
probably due to the presence of two HBSs on the TFHBSww
oligonucleotide compared with only one HBS in the EPOHBS
oligonucleotide.
Tf mRNA Is Not Induced in ARNT/HIF-1b-deficient
Hepa1C4 Cells—To investigate whether HIF-1 is capable of
hypoxically inducing the endogenous Tf gene, we made use of
the ARNT/HIF-1b-deficient Hepa1C4 cell line, which was cul-
tured at 20% or 1% O2 and analyzed by RNA blotting and
hybridization. In previous experiments, we have demonstrated
a lack of hypoxic aldolase mRNA induction and a reduction in
hypoxic VEGF mRNA induction in this cell line (19). Whereas
in the parental ARNT/HIF-1b-positive Hepa1 cell line hypoxia
reproducibly induced Tf mRNA by a factor of 1.5 over the
normoxic control, Hepa1C4 cells did not show induction of Tf
mRNA (Fig. 9). This is in agreement with the lack of HIF-1
DNA-binding activity to the TfHBSww probe in these cells
(shown in Fig. 6B) and, despite the rather low Tf mRNA ex-
pression levels and hypoxic inducibility in this particular hep-
atoma cell line, confirms that HIF-1 is critically involved in the
oxygen responsiveness of the Tf gene.
DISCUSSION
Tf Is a New Member of the HIF-1-regulated Gene Family—
HIF-1 was originally defined by its capability of binding to a
site required for hypoxic induction of Epo gene transcription
(16, 17). Other examples of HIF-1-dependent oxygen-regulated
genes include those encoding for glycolytic enzymes (27–30),
vascular endothelial growth factor (VEGF, Refs. 31–33), induc-
ible nitric oxide synthase (34), and glucose transporter-1
(Glut-1, Ref. 35). We have previously found that Tf gene ex-
pression is hypoxically induced in HepG2 hepatoma cells (10).
FIG. 6. HIF-1 subunits transactivate Tf HBS-containing re-
porter gene constructs. Hep3B cells were transiently co-transfected
with HIF-1a and ARNT/HIF-1b expression vectors together with the Tf
HBS-containing luciferase reporter gene construct pGLTfHBSww, the
control vector pCMVlacZ, and the unrelated plasmid pBluescript to
equalize the total amount of DNA per transfection. Following normoxic
or hypoxic exposure, luciferase activity was determined, corrected for
transfection efficiency and extract preparation yield according to the
b-galactosidase activity, and normalized to the normoxic value of pGLT-
fHBSww control transfection, which was arbitrarily defined as 1.
Means 6 S.D. of three independent experiments are shown.
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In this paper, we demonstrate that this effect is also mediated
by HIF-1 via binding of two HBSs present in the Tf enhancer.
We and others recently characterized a previously obtained
mouse hepatoma cell line (Hepa1C4), which lacks functional
ARNT expression, and demonstrated that it is also devoid of
functional HIF-1 expression in terms of DNA binding activity
and reporter gene transactivation (19, 33, 36, 37). By using
these Hepa1C4 cells, we found that ARNT/HIF-1b is necessary
for formation of the hypoxia-inducible complex binding to the
Tf HBSs. Moreover, hypoxic induction of the endogenous Tf
gene is also abrogated in Hepa1C4 cells, suggesting that HIF-1
is critically involved in oxygen-regulated Tf gene expression.
Architecture of the Tf HBS—An interesting feature of the Tf
enhancer is the presence of two functional HBSs in close vicin-
ity to each other. Such an architecture was not found in the Epo
39 HBS. The finding that a single HBS derived from the Epo
HBS was not sufficient to convey oxygen responsiveness to a
heterologous promoter driving expression of a reporter gene,
although the HIF-1 complex bound to this site in vitro (24),
raised the question as to whether additional functional cis-
acting elements are necessary for full activation. Such an ad-
ditional element (CACA) was found close to the HBSs in the
Epo (16) and VEGF genes (33), as well as in the genes encoding
several glycolytic enzymes (30). The transacting factors bind-
ing to this element, however, still remain to be identified. As
suggested by the hypoxic induction of reporter gene expression
by concatamerized HBSs, such an additional element could
also be the HIF-1 site itself (Refs. 24 and 27 and this report). In
addition, an activator protein (AP-1) site in the vicinity of the
HIF-1-binding HBS in the 59 flanking region of the VEGF gene
(31) and a cAMP-responsive element close to the two consensus
HBSs in the LDH gene (28) have been implicated in full hy-
poxic induction of gene expression. Protein-DNA interactions of
cAMP-responsive element-binding transcription factors (ATF-1
and CREB-1) were also observed within the HIF-1 site of the
Epo HBS itself (24). In conclusion, it seems to be a common
feature of an HBS that a single HBS in isolation is not suffi-
cient to convey full hypoxic activation of gene expression. The
additional factors required for full activation, however, might
differ between the oxygen-regulated genes.
FIG. 7. HIF-1 binds to the Tf HBSs. A, HIF-1 DNA binding activity was assessed by EMSA using the oligonucleotide probes described in Fig.
4 and nuclear extracts derived from Hep3B cells cultured at normoxic or hypoxic conditions for 4 h. B, widespread hypoxia-inducible DNA binding
activity to the wild type TfHBSww probe in Tf expressing (Hep3B and Hepa1) and non-expressing cell lines (HeLa and L929). Hepa1C4 is a subline
of the mouse hepatoma Hepa1, lacking functional ARNT/HIF-1b. C, supershift analysis of HIF-1 bound to the TfHBS probes or to the EPOHBS
probe using polyclonal rabbit antibodies derived against HIF-1a and ARNT/HIF-1b.
FIG. 8. Both Tf HBS sites are capable of HIF-1 DNA binding. EMSA competition experiments using an increasing molar excess of unlabeled
oligonucleotide (Fig. 4) as indicated. Nuclear extracts were derived from Hepa1 cells cultured at 20% or 1% O2 for 4 h.
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Protein-DNA Interactions at the Tf HBS—As mentioned
above, the hypoxia-inducible Tf enhancer region is composed of
two adjacent HBSs, both of which are capable of conveying
hypoxic induction to reporter gene expression. The two 8-bp
HBSs in the Tf enhancer are spaced by 9 bp only (Fig. 4),
raising the question whether two HIF-1 complexes could bind
simultaneously to these two sites or whether due to sterical
hindrance only one complex can bind at once. As shown by the
equal migration properties of TfHBS (wild type and single
mutant) and EPO HBS probes in our EMSAs, the predominant
protein-DNA complex might consist of only one HIF-1 het-
erodimer bound to the TfHBSww oligonucleotide. Although
EMSA analysis is probably not the ideal method to determine
molecular mass differences, we would predict that an increase
of more than 200 kDa (the molecular mass of an additional
HIF-1 heterodimer) should be detectable.
The two core sequences TACGTGCA and TACGTGCG (note
that the complementary strand to that shown in Fig. 4 is given)
conform well with a previously published (33) consensus HBS
(BACGTGSK, where B is C or G or T, S is C or G, and K is G or
T). Strikingly, the presence of an adenosine residue at position
8 of the 8-bp consensus sequence (found in the 59 TfHBS) has
never been reported in any of the so far published genes car-
rying HBSs (18). Moreover, positions 9 and 10 also did not
contain an adenosine residue in these HBSs (not shown). Thus,
one would predict that this lack of adenosine residues in the 39
part of the HBS is of functional relevance and that the DNA
binding affinity of HIF-1 for the 59 Tf HBS might be decreased.
Surprisingly, as shown with mutated oligonucleotide probes
and competition experiments, the 39 rather than the 59 HIF-1
site (which contains the unexpected adenosine residue) con-
stantly produced lower HIF-1 band intensities in EMSAs. On
the functional level, only mutation of the 59 Tf HBS signifi-
cantly reduced (but did not completely abolish) hypoxic induc-
tion of reporter gene expression, confirming that the 59 HBS is
more effective in HIF-1 binding than the 39 HBS. Thus, despite
the considerable number of so far identified HBSs, a conclusive
consensus sequence still remains to be determined.
How Is HIF-1 Itself Activated?—Having established that
HIF-1 is mediating hypoxic induction of Tf gene expression, the
question arises of how HIF-1 itself is activated. So far, little is
known about the mechanisms of oxygen sensing and subse-
quent conditional regulation of HIF-1. Initially, it has been
reported that HIF-1a (and to a lesser extent also ARNT/HIF-
1b) is regulated at the level of mRNA expression (17), but work
from our and other laboratories could not confirm this result
(19, 38, 39). Hence, HIF-1 must be regulated at the post mRNA
level. Possible mechanisms include translational up-regula-
tion, post-translational protein stabilization (39) or protein
modifications such as phosphorylation (40) or redox modifica-
tions (41). There is good evidence for all of these putative
mechanisms and more than one might turn out to be involved
in hypoxic HIF-1 activation (reviewed in Ref. 18). Interestingly,
our transient overexpression experiments using the Tf HBS
demonstrated that forced expression of the two HIF-1 subunits
is sufficient to convey induction to reporter gene transcription
even under normoxic conditions. This observation is in agree-
ment with recent work using the Epo HBS (19, 42) and VEGF
HBS (33). Since conditional regulation thus does not seem to be
of primary importance for HIF-1 function, we favor the mod-
el(s) of translational up-regulation and/or protein stabilization.
However, hypoxia represented a stronger stimulus than over-
expression of HIF-1, indicating that for a full response condi-
tional regulation of HIF-1 is required. Further investigations of
HIF-1 regulation is crucial for the elucidation of the signal
transduction pathway(s) involved in the expression of Tf as
well as other oxygen-regulated genes.
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